Renal disease as a determinant of increased lipoprotein(a) concentrations in diabetic patients

被引:10
|
作者
Boemi, M
Sirolla, C
Fumelli, P
James, RW [1 ]
机构
[1] Univ Hosp Geneva, Div Endocrinol & Diabetol, Clin Diabet Unit, CH-1211 Geneva 14, Switzerland
[2] Inst Natl Riposa Cura Anziani, Div Diabetol, Ancona, Italy
[3] Inst Natl Riposa Cura Anziani, Dept Demog & Stat Studies, Ancona, Italy
关键词
D O I
10.2337/diacare.22.12.2033
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE - This study examined the hypothesis that kidney function is an independent determinant of lipoprotein(a) [Lp(a)] concentrations in people with diabetes. RESEARCH DESIGN AND METHODS - Lp(a) concentrations were measured in plasma samples from 273 type 2 and 223 type 1 diabetic patients recruited from a diabetes clinic. Kidney function was categorized as normal or pathological according to plasma creatinine levels and creatinine clearance rates. RESULTS - Macroalbuminuria was uniformly associated with significantly raised plasma concentrations of Lp(a) regardless of the marker used to identify kidney dysfunction. In contrast, in patients with microalbuminuria, significantly raised plasma Lp(a) levels were observed only when creatinine clearance rates or plasma creatinine levels indicated pathological kidney function. These conclusions were independent of diabetes type. CONCLUSIONS - In microalbuminuria and apparently in normoalbuminuria, altered kidney function determined by creatinine clearance rates or creatinine levels appears to be a major determinant of raised Lp(a) levels in both type 1 and type 2 diabetic patients. In contrast, Lp(a) concentrations were uniformly raised in patients with macroalbuminuria.
引用
收藏
页码:2033 / 2036
页数:4
相关论文
共 50 条
  • [1] INCREASED LIPOPROTEIN(A) CONCENTRATIONS IN CHRONIC-RENAL-FAILURE
    HAFFNER, SM
    GRUBER, KK
    ALDRETE, G
    MORALES, PA
    STERN, MP
    TUTTLE, KR
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1992, 3 (05): : 1156 - 1162
  • [2] Multiple lipoprotein abnormalities in type I diabetic patients with renal disease
    Groop, PH
    Elliott, T
    Ekstrand, A
    FranssilaKallunki, A
    Friedman, R
    Viberti, GC
    Taskinen, MR
    DIABETES, 1996, 45 (07) : 974 - 979
  • [3] LIPOPROTEIN(A) IN TYPE-1 DIABETIC-PATIENTS WITH RENAL-DISEASE
    GROOP, PH
    VIBERTI, GC
    ELLIOTT, TG
    FRIEDMAN, R
    MACKIE, A
    EHNHOLM, C
    JAUHIAINEN, M
    TASKINEN, MR
    DIABETIC MEDICINE, 1994, 11 (10) : 961 - 967
  • [4] Increased Renal Cortical Stiffness in Patients with Advanced Diabetic Kidney Disease
    Koc, Ayse Selcan
    Sumbul, Hilmi Erdem
    Gulumsek, Erdinc
    SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2019, 30 (01) : 138 - 150
  • [5] Lipoprotein(a) and cardiovascular disease in diabetic patients
    Qi, Qibin
    Qi, Lu
    CLINICAL LIPIDOLOGY, 2012, 7 (04) : 397 - 407
  • [6] LIPID AND LIPOPROTEIN (A) CONCENTRATIONS IN RENAL-TRANSPLANT PATIENTS
    WEBB, AT
    PLANT, M
    REAVELEY, DA
    ODONNELL, M
    LUCK, VA
    OCONNOR, B
    SEED, M
    BROWN, EA
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1992, 7 (07) : 636 - 641
  • [7] Riboflavin is a determinant of total homocysteine plasma concentrations in end-stage renal disease patients
    Skoupy, S
    Födinger, M
    Veitl, M
    Perschl, A
    Puttinger, H
    Röhrer, C
    Schindler, K
    Vychytil, A
    Hörl, WH
    Sunder-Plassmann, G
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 (05): : 1331 - 1337
  • [8] Apolipoprotein(a) phenotypes and lipoprotein(a) concentrations in patients with renal failure
    Milionis, HJ
    Elisaf, MS
    Tselepis, A
    Bairaktari, E
    Karabina, SA
    Siamopoulos, KC
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1999, 33 (06) : 1100 - 1106
  • [9] Increased plasma concentrations of lipoprotein(a) for every phenotype of apolipoprotein(a) in patients with chronic renal failure treated by hemodialysis
    Gazzaruso, C
    Bonetti, G
    Garzaniti, A
    Pini, G
    Ragazzoni, A
    Bianchi, C
    Jucci, A
    Buscaglia, P
    Geroldi, D
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 1996, 6 (04) : 203 - 210
  • [10] INCREASED PLASMA LIPOPROTEIN(A) LEVELS IN PATIENTS WITH END-STAGE RENAL-DISEASE
    DIEPLINGER, H
    LACKNER, C
    KONIG, P
    UTERMANN, G
    ARTERIOSCLEROSIS, 1990, 10 (05): : A860 - A860